CapsoVision, Inc (CV) intrinsic value & 10-year financials

CapsoVision, Inc (CV) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 3 fiscal years revenue grew 15.3% a year to $13.6M, with an average return on invested capital of 26.2%.

Graham intrinsic value
—
Share price (Oct 17, 2026)
$6.53
Market cap
$160.3M
Revenue (FY2025)
$13.6M
Revenue growth (3-yr CAGR)
15.3%
ROIC (10-yr avg)
26.2%
Free cash flow (FY2025)
-$23.0M

CV 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $13.6M -$25.3M -$1.03 -$23.0M -188.3% 38.0%
FY2024 $11.8M -$19.9M -$0.82 -$20.2M -169.4% 14.4%
FY2023 — — — — — —

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

CapsoVision, Inc revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.

CapsoVision, Inc has earned high returns on invested capital, averaging 26.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.

CapsoVision, Inc capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, CapsoVision, Inc is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-34.21 per share.

CV stock: frequently asked questions

What is the intrinsic value of CapsoVision, Inc (CV) stock?

Graham's formula only works with positive earnings. CapsoVision, Inc reported diluted EPS of -$1.03 in fiscal 2025, so no Graham value is shown. The 10-year table shows revenue and cash-flow trends instead.

Does CapsoVision, Inc generate free cash flow?

CapsoVision, Inc generated -$23.0M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 0 of the last 2 reported years.

What is CV's return on invested capital?

Average ROIC over the last 3 fiscal years was 26.2%, and average return on equity was 30.1%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this CV data come from?

From CapsoVision, Inc's annual 10-K filings on SEC EDGAR, most recently filed Aug 13, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar electromedical & electrotherapeutic apparatus stocks